Olawade David B, Wada Ojima Z, Fidelis Sandra Chinaza, Oluwole Oluwafemi S, Alisi Chibuike S, Orimabuyaku Nifemi F, Clement David-Olawade Aanuoluwapo
Department of Allied and Public Health, School of Health, Sport and Bioscience, University of East London, London, United Kingdom.
Department of Research and Innovation, Medway NHS Foundation Trust, Gillingham ME75NY, United Kingdom.
Sci One Health. 2024 Oct 28;3:100085. doi: 10.1016/j.soh.2024.100085. eCollection 2024.
Mpox, formerly known as Monkeypox, is a viral zoonotic disease endemic to Central and West Africa that has posed significant public health challenges since its identification in 1970. Despite decades of experience in managing outbreaks, the 2022-2024 Mpox outbreaks exposed substantial gaps in global preparedness and response, leading the World Health Organization (WHO) to declare a Public Health Emergency of International Concern (PHEIC) in 2022. The resurgence of cases in Europe in 2022 and the more recent emergence of the virulent clade Ⅰb in the Democratic Republic of the Congo (DRC) in 2024 have highlighted a critical need for improved proactive and response strategies to curb the epidemic. This narrative review examines the historical and recent epidemiology of Mpox in Africa and explores the factors that have limited effective management. These include objective influences such as viral mutations, zoonotic transmission patterns, and environmental changes like deforestation, as well as subjective factors, including delayed responses, limited vaccine availability, cessation of smallpox vaccinations, and inequitable access to healthcare. In particular, the review emphasizes the ongoing disparities in global health equity, as wealthier nations have been able to secure vaccines and therapeutics quickly, while endemic regions in Africa continue to struggle with limited resources. The review also discusses how socio-economic and cultural factors, combined with weak public health infrastructure and inadequate surveillance systems, perpetuate cycles of outbreak in vulnerable populations. Furthermore, the emergence of clade Ⅰb in 2024, with its higher virulence and mortality rates among children, particularly in rural areas, underscores the urgency of addressing the evolving epidemiological landscape of Mpox. In response to these challenges, this review recommends strengthening healthcare infrastructure, enhancing surveillance systems, ensuring equitable access to vaccines and treatments, and integrating environmental management into public health strategies. Global collaboration remains essential to provide African countries with the resources and support needed to manage and prevent future outbreaks effectively. Without these measures, the world risks a prolonged public health crisis with far-reaching consequences for both Africa and the global community.
猴痘,以前称为猴天花,是一种病毒性人畜共患病,在中非和西非流行,自1970年被发现以来,对公共卫生构成了重大挑战。尽管在管理疫情方面有几十年的经验,但2022-2024年的猴痘疫情暴露出全球防范和应对方面的重大差距,导致世界卫生组织(WHO)在2022年宣布国际关注的突发公共卫生事件(PHEIC)。2022年欧洲病例的再次出现以及2024年刚果民主共和国(DRC)出现的更具毒性的Ⅰb分支,凸显了改进主动和应对策略以遏制疫情的迫切需求。这篇叙述性综述研究了非洲猴痘的历史和近期流行病学,并探讨了限制有效管理的因素。这些因素包括病毒突变、人畜共患病传播模式和森林砍伐等环境变化等客观影响,以及反应迟缓、疫苗供应有限、天花疫苗接种停止和医疗保健获取不平等的主观因素。特别是,该综述强调了全球卫生公平方面持续存在的差距,因为较富裕的国家能够迅速获得疫苗和治疗方法,而非洲的流行地区继续在资源有限的情况下苦苦挣扎。该综述还讨论了社会经济和文化因素,加上薄弱的公共卫生基础设施和不足的监测系统,如何在弱势群体中使疫情循环持续存在。此外,2024年出现的Ⅰb分支,在儿童中,特别是在农村地区,具有更高毒力和死亡率,凸显了应对猴痘不断演变的流行病学形势的紧迫性。为应对这些挑战,本综述建议加强医疗基础设施,加强监测系统,确保公平获得疫苗和治疗方法,并将环境管理纳入公共卫生战略。全球合作对于为非洲国家提供有效管理和预防未来疫情所需的资源和支持仍然至关重要。如果不采取这些措施,世界面临长期公共卫生危机的风险,这将对非洲和全球社会产生深远影响。